Suppr超能文献

阿替洛尔和地尔硫䓬治疗变异性心绞痛患者的作用机制研究。

Investigation of therapeutic mechanisms of atenolol and diltiazem in patients with variable-threshold angina.

作者信息

Nadazdin A, Davies G J

机构信息

Department of Medicine, Royal Postgraduate Medical School, Hammersmith Hospital, London, UK.

出版信息

Am Heart J. 1994 Feb;127(2):312-7. doi: 10.1016/0002-8703(94)90118-x.

Abstract

The effects of beta-adrenoreceptor and calcium channel-blocking agents on the balance of myocardial oxygen supply and demand were studied in 15 patients (2 women and 13 men), aged 46 to 69 (mean 62) years, with variable-threshold angina. An exercise test was performed before therapy was begun, and 24-hour ambulatory ECG monitoring was performed after 1 week of long-acting nitrate therapy, in the third week after random assignment to either atenolol or diltiazem, and in the third week after crossover. All exercise tests were positive except in one patient taking diltiazem. The exercise time to 0.1 mV ST change was 4.2 +/- 1.7 minutes with no therapy, 5.1 +/- 1.6 minutes with nitrates, 6.6 +/- 0.8 minutes with diltiazem, and 6.5 +/- 2.1 minutes with atenolol. The rate-pressure product at 0.1 mV ST change was 20.9 +/- 4.6 with no therapy and 21.2 +/- 5.7 and 22 +/- 4.6 with nitrates and diltiazem, respectively, but fell to 15 +/- 3.9 beats.min.-1 mm Hg 10(-3) after atenolol (p < 0.01). There was no significant difference in the number of anginal attacks or in nitroglycerin consumption per week. The heart rate at the onset of ST-segment change during the exercise test and during ambulatory ECG monitoring was significantly lower during atenolol than during diltiazem treatment. Both atenolol and diltiazem were of similar efficacy in increasing nonischemic exercise duration in patients with variable-threshold angina and acted primarily by slowing the resting heart rate.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

对15例(2例女性,13例男性)年龄在46至69岁(平均62岁)的变异性心绞痛患者,研究了β-肾上腺素能受体阻滞剂和钙通道阻滞剂对心肌氧供需平衡的影响。在开始治疗前进行了运动试验,并在长效硝酸盐治疗1周后、随机分配至阿替洛尔或地尔硫䓬治疗的第3周以及交叉治疗后的第3周进行了24小时动态心电图监测。除1例服用地尔硫䓬的患者外,所有运动试验均为阳性。无治疗时,ST段改变0.1 mV的运动时间为4.2±1.7分钟,硝酸盐治疗时为5.1±1.6分钟,地尔硫䓬治疗时为6.6±0.8分钟,阿替洛尔治疗时为6.5±2.1分钟。ST段改变0.1 mV时的心率血压乘积,无治疗时为20.9±4.6,硝酸盐治疗时为21.2±5.7,地尔硫䓬治疗时为22±4.6,但阿替洛尔治疗后降至15±3.9次·分钟-1·毫米汞柱×10-3(p<0.01)。每周心绞痛发作次数或硝酸甘油消耗量无显著差异。运动试验和动态心电图监测期间ST段改变开始时的心率,阿替洛尔治疗时显著低于地尔硫䓬治疗时。阿替洛尔和地尔硫䓬在增加变异性心绞痛患者非缺血性运动持续时间方面疗效相似,主要作用是减慢静息心率。(摘要截选至250字)

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验